| NYSE MKT: DXR
Daxor Corp. is an innovative medical instrumentation and biotechnology company. The company's focus has been the creation and development of the BVA-100 blood volume analyzer, an instrument that rapidly and accurately measures human blood volume. It operates through the following segments: Equipment Sales and Related Services and Cryobanking and Related Services. The Equipment Sales and Related Services segment comprises the blood volume analyzer equipment and related activity. It includes equipment sales, equipment rentals, equipment delivery, BVA-100 kit sales and service contracts. The Cryobanking and Related Services segment is comprised of activity relating to the storage of blood and semen, and related laboratory services and handling. Daxor was founded in 1970 and is headquartered in New York, NY.